Spironolactone Tablet
Product Images NDC 54348-340

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 54348-340). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmpak, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label4 (Label4)

Prescription medication label for Spironolactone tablets, 50 mg strength, bottle of 90 tablets. The label includes storage instructions, manufacturer PharmPak, and packaging details. The printable patient section notes the medication name, strength, quantity, and manufacturer Amneal, with partial dosing instructions in English and Spanish.*

FDA Label Image

20 (Spironolactone Tablets Usp 1)

Chemical structure of spironolactone, a human prescription drug active ingredient shown as a molecular diagram with distinct rings, functional groups, and bonding patterns visible.*

FDA Label Image

10 (Spironolactone Tablets Usp 2)

A Kaplan-Meier survival probability curve comparing Spironolactone versus placebo over 48 months. The y-axis shows probability from 0 to 1, and the x-axis represents time in months. Two lines represent spironolactone (n=822) and placebo (n=841), with a log-rank p-value of < 0.001 indicating statistical comparison.*

FDA Label Image

10 (Spironolactone Tablets Usp 3)

A forest plot chart depicting hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups related to Spironolactone use compared to placebo. Subgroups include age, sex, race, LVEF percentage, heart failure status, NYHA class, diabetes presence, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACEI, and beta-blocker use. The horizontal axis shows HR values from 0.2 to 1.4, indicating comparative effectiveness between Spironolactone and placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.